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Abstract 
 
BACKGROUND: Early-life stressful events affect the neurobiological maturation of cerebral 
circuitries including the endogenous opioid system and the effects elicited by adolescent cocaine 
exposure on this system have been poorly investigated. Here, we evaluated whether cocaine 
exposure during adolescence causes short- or long-term alterations in mRNAs codifying for 
selected elements belonging to the opioid system. Moreover, since brain-derived neurotrophic 
factor (BDNF) may undergo simultaneous alterations with the opioid peptide dynorphin, we also 
evaluated its signaling pathway as well. 
METHODS: Adolescent male rats were exposed to cocaine (20 mg/kg/day) from post-natal day 
(PND) 28 to PND42, approximately corresponding to human adolescence. After short- (PND45) or 
long-term (PND90) abstinence, prodynorphin-κ-opioid receptor (pDYN-KOP) and pronociceptin-
nociceptin receptor (pN/OFQ-NOP) gene expression were evaluated in the nucleus accumbens 
(NAc) and hippocampus (Hip) together with the analysis of BDNF signaling pathways. 
RESULTS: In the NAc of PND45 rats, pDYN mRNA levels were up-regulated, an effect paralled 
by increased BDNF signaling. Differently from NAc, pDYN mRNA levels were down-regulated in 
the Hip of PND45 rats without significant changes of BDNF pathway. At variance from PND45 
rats, we did not find any significant alteration of the investigated parameters either in NAc and Hip 
of PND90 rats. 
CONCLUSIONS: Our results indicate that the short-term withdrawal from adolescent cocaine 
exposure is characterized by a parallel pDYN mRNA and BDNF signaling increase in the NAc. 
Given the depressive-like state experienced during short abstinence in humans, we hypothesize that 
such changes may contribute to promote the risk of cocaine abuse escalation and relapse. 
Keywords: cocaine, adolescence, dynorphin; opioid receptor, nociceptin, BDNF 
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1. Introduction 
Adolescents represent the population at highest risk of abuse-related behaviors because of their 
impulsivity and higher vulnerability to the reinforcing properties of drugs of abuse; in addition, they 
appear to suffer the severe effects of abstinence to a lesser extent (Acheson et al., 1999; Doherty et 
al., 2009; Li and Frantz, 2009). In this regard, relevant evidence showed that the cue-induced 
reinstatement of cocaine seeking after withdrawal was attenuated in rats exposed to cocaine during 
adolescence compared with rats exposed during adulthood (Li and Frantz, 2009). 
Adolescence is a crucial stage of brain development (Casey et al., 2008; Ernst and Korelitz,  2009), 
during which cortical and limbic brain regions mature following a specific temporal profile (Spear 
2000; Caballero et al., 2016) providing a critical neurochemical network responsible for the 
maturation of cognitive processes. 
Our group recently demonstrated that exposure to cocaine during adolescence may impact the 
developing brain. Indeed, a single cocaine exposure is sufficient to alter neuroplasticity in the 
adolescent brain (Giannotti et al., 2015; Caffino et al., 2017; Caffino et al., 2018) whereas repeated 
exposure to the psychostimulant during adolescence causes short- as well as long-term alterations at 
behavioral, molecular and structural level (Giannotti et al., 2013, 2014; 2016; Caffino et al., 2014, 
2015a, 2018). These lines of evidence have been corroborated by structural and functional evidence 
from Gourley’s group showing that exposure to cocaine during adolescence impairs cognitive tasks 
and brain plasticity (Gourley et al., 2012; DePoy et al., 2014, 2017; Hinton et al., 2014). 
Interestingly, early-life manipulations have also been shown to involve changes in the 
endogenous opioid system (Ploj and Nylander, 2003; Ploj et al., 2002), prompting us to hypothesize 
that interfering with the developing brain, i.e. exposing adolescent rats to cocaine, may impact such 
system. Actually, several lines of evidence indicate that different addictive substances such as 
cocaine, alcohol and heroin affect the endogenous opioid system (D’Addario et al. 2007a, 2013a, 
2013b; Sillivan et al., 2013; Caputi et al., 2014, 2016) and corroborate the hypothesis that this 
system might represent a promising target for addiction therapy (Lutz and Kieffer, 2013; Belzeaux 
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et al., 2018). In details, the dynorphinergic system has long been proposed to mediate negative 
emotional states and, indeed, it is strongly involved in stress-induced reinstatement of cocaine 
seeking (Valdez et al., 2007; Mantsch et al., 2016). Another endogenous peptide, known as 
nociceptin/orphanin FQ (N/OFQ), acts as critical mediator in the hedonic dysregulation (Devine et 
al., 2001; Sakoori and Murphy, 2008) mainly attenuating the stress-like responses (Ciccocioppo et 
al., 2003; Martin-Fardon et al., 2010). In this regard, we recently reported that chronic cocaine 
infusion induces significant neurochemical alterations in prodynorphin - κ-opioid receptor (pDYN-
KOP) and in the proN/OFQ - nociceptin receptor (pN/OFQ-NOP) systems in limbic regions, an 
effect paralleled by consistent histone modifications (Caputi et al., 2014). 
Based on these experimental lines of evidence, the present study aimed at evaluating whether 
rats exposed to cocaine during adolescence exhibit short- or long-lasting alterations in pDYN-KOP 
and pN/OFQ-NOP systems. Further, since dynorphin has been proposed as a downstream effector 
of the brain-derived neurotrophic factor (BDNF) and given that the pDYN expression pattern might 
parallel that of BDNF (Croll et al., 1994; Kim et al., 2000; Logrip et al., 2008), we also evaluated 
whether repeated cocaine exposure during adolescence may dysregulate BDNF signaling after short 
or long-term abstinence. 
To address these questions, we exposed male rats to prolonged cocaine administration from 
postnatal day (PND) 28 to PND 42, a period of development that roughly approximates adolescence 
in humans (Collins and Izenwasser, 2004). Animals were sacrificed at PND45 or PND90 to 
evaluate the alteration pattern of endogenous opioids (pDYN-KOP and pN/OFQ-NOP systems) and 
BDNF signaling following short- and long-term withdrawal. We focused our analysis on the 
nucleus accumbens (NAc), which plays a critical role in the reinforcing properties of cocaine (Di 
Chiara et al., 2004). Further, we analyzed the hippocampus (Hip) that is crucial for the negative 
emotional state occurring during drug abstinence (Koob, 2012) and also because of its feature to 
undergo periodic structural and functional changes from adolescence to adulthood (Koehl, 2015; 
Risher et al., 2015; Zhu et al., 2016). 
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To pursue this issue, we decided to take advantage of a previously conducted experiment (Giannotti 
et al., 2014) with a dual purpose: 1) to use tissues from rats that already showed neuroplastic 
changes as a consequence of developmental exposure to cocaine and 2) to adhere with the Animal 
Research Reporting of In Vivo Experiments (ARRIVE) guidelines, which ask to maximize 
information published and to minimize unnecessary studies reducing the numbers of animals 
whenever possible. 
2. Materials and methods 
2.1 Experimental procedures 
Sprague-Dawley male rats used in this study were obtained from Charles River (Calco, Italy), and 
housed under standard conditions of temperature and humidity under artificial light (from 07:00 to 
19:00 hours). A maximum of two male siblings was taken from each litter in order to reduce “litter 
effects” (Chapman and Stern, 1978). Male rats were treated subcutaneously with cocaine (20 
mg/kg/day) (MacFarlan-Smith, Edinburgh, UK) or saline from PND28 to PND42, a period that 
include periadolescence (PND 28-35) and the beginning of mid adolescent rat phases, and that 
roughly approximates adolescence in humans (Collins and Izenwasser, 2004). In order to avoid any 
stress due to unpredictability of the treatment, animals were always treated in the morning at the 
same time. Following the end of this treatment, animals were left undisturbed in their home cages 
until the time of sacrifice, PND45 or PND90. 
The NAc (approximately + 2.76 to + 0.84 mm from Bregma) and the Hip (grossly dissected) 
were collected from freshly dissected brain (Paxinos and Watson, 2005), immediately frozen on dry 
ice and stored at -80°C. All animal procedures were carried out in accordance with the NIH Guide 
for the Care and Use of Laboratory Animals (2011 edition) and EU directives and guidelines (EEC 
Council Directive 2010/63/UE). All efforts were made to minimize animal suffering and to keep the 
lowest number of animals used. Experiments have been reported in compliance with the ARRIVE 
guidelines. 
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2.1 RNA Preparation and Real-Time Quantitative RT-PCR 
Total RNA was isolated from one single hemisphere of NAc and Hip by single step guanidinium 
isothiocyanate/phenol extraction using PureZol RNA isolation reagent (Bio-Rad Laboratories, 
Segrate, Milan, Italy) according to the manufacturer’s instructions. Following total RNA extraction, 
the samples were processed for quantitative real-time reverse transcription polymerase chain 
reaction (real time qRT-PCR) to assess mRNA levels. 
In brief, RNA integrity was checked by 1% agarose gel electrophoresis and RNA 
concentrations were measured by spectrophotometry (OD260/OD280 1.8 > ratio >2). Total RNA 
was reverse transcribed with the GeneAmp RNA PCR kit (Life Technologies) and the relative 
abundance of each mRNA of interest was assessed by real-time qRT-PCR using the Syber Green 
gene expression Master Mix (Life Technologies) in a Step One Real-Time PCR System (Life 
Technologies). All data were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
as the endogenous reference gene. Relative expression of different gene transcripts was calculated 
by the Delta-Delta Ct (DDCt) method and converted to relative expression ratio (2−DDCt) for 
statistical analysis (Livak and Schmittgen, 2001). Results are represented as fold change in mRNA 
levels. The primers used for PCR amplification were designed using Primer 3 and are reported in 
Table 1. 
 
2.2 Preparation of protein extracts and Western blot analyses 
The other hemisphere of NAc and Hip was homogenized in a glass-glass potter using a cold buffer 
containing 0.32 M sucrose, 1mM Hepes solution, 0.1 mM EGTA, 0.1 mM PMSF, pH=7.4, in 
presence of a complete set of protease inhibitors and a phosphatase inhibitor cocktail, and then 
sonicated. Homogenate was prepared as previously described (Fumagalli et al., 2009). Total 
proteins were measured in the whole homogenate by the Bio-Rad Protein Assay, using bovine 
serum albumin as the calibration standard (Bio-Rad Laboratories, Milan, Italy). Equal amounts of 
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protein were run under reducing conditions on the criterion TGX precast gels (Bio-Rad 
Laboratories, Milan, Italy) and then electrophoretically transferred onto polyvinylidene difluoride 
membranes (GE Healthcare, Milan, Italy). 
Blots were blocked one hour at room temperature with 10% non-fat dry milk in TBS + 0,1% 
Tween-20 buffer, incubated with antibodies against the phosphorylated forms of the proteins and 
then stripped and reprobed with the antibodies against corresponding total proteins. The 
conditions of the primary antibodies were the following: proBDNF (1:2000, GeneTex, USA); 
mBDNF (1:500, Icosagen, Estonia); anti total trkB (1:750, Santa Cruz Biotechnology, USA); anti 
phopsho-ERK2 T202/204 (1:1000, Cell Signaling Technology, USA); anti total ERK2 (1:5000, 
Cell Signaling Technology, USA); anti phopsho-Akt S473 (1:1000, Cell Signaling Technology, 
USA); anti total Akt (1:1000, Cell Signaling Technology, USA) and anti β-Actin (1:10000, 
Sigma-Aldrich, Italy). Results were standardized using β-actin as the control protein, which was 
detected by evaluating the band density at 43 kDa. Immunocomplexes were visualized by 
chemiluminescence using the Chemidoc MP Imaging System (Bio-Rad Laboratories). 
 
2.4 Statistical Analysis 
Data were collected from individual animals and are reported as the mean of values ± standard error 
of the mean (SEM) (n/assay = 6). qPCR results, produced by short- (PND45) and long-term 
(PND90) abstinence from chronic cocaine exposure, were statistically analyzed by two-way 
analysis of variance (ANOVA) followed by Bonferroni post hoc test. Western blotting results were 
analyzed by unpaired Student’s t test. Subjects were eliminated from the final dataset if their data 
deviated from the mean by 2 SDs (standard deviations). Statistical analysis was performed using 
GraphPad Prism software package (version 5.00 for Windows, GraphPad Software, San Diego CA, 
USA, www.graphpad.com) and statistical significance was set at p < 0.05. 
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3. Results 
3.1 Gene expression analysis 
Rats were sacrificed at PND45 and PND90, i.e. 3 and 48 days after the last exposure to cocaine or 
saline. Gene expression analysis was performed via qRT-PCR in the NAc and Hip of saline- and 
cocaine-treated rats. 
In the NAc, adolescent cocaine exposure promoted a significant increase of pDYN mRNA levels at 
PND45 (1.45 ± 0.11 vs saline 1.00 ± 0.04, F(1,20) = 4.04, p < 0.05) (Fig. 1a) with no significant 
changes detected for the other investigated genes (KOP at PND45: 1.09 ± 0.11 vs saline 1.00 ± 
0.09, n.s.; pN/OFQ at PND45: 1.03 ± 0.04 vs saline 1.00 ± 0.05, n.s.; NOP at PND45: 1.14 ± 0.09 
vs saline 1.00 ± 0.06, n.s.) (Fig.1). At PND90, no changes were observed in the cocaine-treated 
group compared with controls (pDYN at PND90: 1.01 ± 0.10 vs saline 1.00 ± 0.16, n.s.; KOP at 
PND90: 0.92 ± 0.09 vs saline 1.00 ± 0.07, n.s.; pN/OFQ at PND90: 1.01 ± 0.05 vs saline 1.00 ± 
0.07, n.s.; NOP at PND90: 1.03 ± 0.09 vs saline 1.00 ± 0.06, n.s.) (Fig. 1). Bonferroni post hoc test 
revealed a significant age x treatment interaction in the analysis of pDYN mRNA levels (F(1, 20) = 
3.77, p < 0.05) (Fig.1a). 
In the Hip, a significant decrease of pDYN mRNA levels was detected at PND45 (0.77 ± 0.02 
vs saline 1.00 ± 0.05, F(1,20) = 17.03, p < 0.01) (Fig. 2a) with no other changes at the same time 
point for the other investigated genes (KOP at PND45: 1.15 ± 0.04 vs saline 1.00 ± 0.12, n.s.; 
pN/OFQ at PND45: 1.05 ± 0.03 vs saline 1.00 ± 0.07, n.s.; NOP at PND45: 1.02 ± 0.06 vs saline 
1.00 ± 0.07, n.s.) (Fig.2). No significant alterations of investigated genes were observed at PND90 
(pDYN at PND90: 0.84 ± 0.06 vs saline 1.00 ± 0.05, n.s.; KOP at PND90: 0.87 ± 0.07 vs saline 
1.00 ± 0.04, n.s.; pN/OFQ at PND90: 1.03 ± 0.05 vs saline 1.00 ± 0.04, n.s.; NOP at PND90: 1.03 ± 
0.04 vs saline 1.00 ± 0.04, n.s.) (Fig. 2). Tabular result of KOP gene expression analysis in the Hip 
indicated that no significant effect was referred to treatment and interaction parameters overall. 
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However, the narrative report showed the presence of a borderline result for interaction parameter. 
Indeed, Bonferroni post hoc test revealed a significant age x treatment interaction in the analysis of 
KOP mRNA levels (F(1, 20) = 3.45, p < 0.05) (Fig.2b). 
 
3.2 Protein analysis 
Fig 3 shows that both the precursor (proBDNF) and the mature form (mBDNF) of BDNF are 
significantly increased in the NAc of cocaine-treated PND45 rats (proBDNF: 141 ± 14 vs saline 
100 ± 11, t(9)= 2.338, p = 0.044; mBDNF: 135 ± 11 vs saline 100 ± 9, t(9)= 2.49, p = 0.034; unpaired 
two-tailed t test; panel a). Panel b shows that the expression of the high affinity BDNF receptor, 
trkB, is up-regulated as well (136 ± 11 vs saline 100 ± 11, t(10) = 2.314, p = 0.043, unpaired two-
tailed t test). In line with the enhancement of BDNF-trkB mediated signalling, we found increased 
phosphorylation of the BDNF-dependent Akt pathway (pAkt S473: 133 ± 5 vs saline 100 ± 9, t(9) = 
3.02, p = 0.015; Akt: 119 ± 7 vs saline 100 ± 9, t(10) = 1.666, p = 0.127, unpaired two-tailed t test; 
panel c) with no changes in ERK2 pathway (pERK2 T202/204: 104 ± 13 vs saline 100 ± 18, t(10) = 
0.18, p = 0.861; ERK2: 109 ± 10 vs saline 100 ± 11, t(10) = 0.605, p = 0.56, unpaired two-tailed t 
test; panel d). 
Fig 4 shows no changes in the hippocampal expression of both proBDNF (99 ± 4 vs saline 100 
± 5, t(10) = 0.158, p = 0.877; unpaired two-tailed t test; panel a) and mBDNF (94 ± 5 vs saline 100 ± 
4, t(10) = 0.914, p = 0.38; unpaired two-tailed t test; panel a) as well as in the BDNF receptor trkB 
(110 ± 7 vs saline 100 ± 5, t(10) = 1.125, p = 0.285; unpaired two-tailed t test; panel b). In line with 
the lack of changes in the neurotrophin, no alterations were observed in both phosphorylation and 
expression of Akt (pAkt S473: 101 ± 6 vs saline 100 ± 8, t(10) = 0.102, p = 0.921; Akt: 104 ± 7 vs 
saline 100 ± 4, t(10) = 0.473, p = 0.645, unpaired two-tailed t test; panel c) and ERK2 pathway 
(pERK2 T202/204: 104 ± 7 vs saline 100 ± 5, t(10) = 0.465, p = 0.652; ERK2: 114 ± 7 vs saline 100 
± 3, t(10) = 1.730, p = 0.112, unpaired two-tailed t test; panel d). 
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4. Discussion  
The major finding of our study is that repeated exposure to cocaine during adolescence evokes 
dynorphinergic alterations that heavily depend on the brain regions investigated. In particular, 
pDYN mRNA levels increased in the NAc while decreasing in the Hip after short-term withdrawal. 
Conversely, no changes were observed for the nociceptin system either after short- or long-term 
withdrawal in both investigated regions. 
The dynorphinergic system is widely distributed within the mesocorticolimbic regions 
(Meng et al., 1993; Simonin et al., 1995) where it is known to mediate stress responses and to play a 
significant role in regulating the reward circuitry. In fact, pDYN-KOP system mediates negative 
emotional responses such as dysphoria, anhedonia, anxiety and depression (McLaughlin et al., 
2006; Land et al., 2008; Bruchas et al., 2008). 
The anhedonic state, primarily mediated by the dynorphinergic system activation, is also the most 
typical sign of withdrawal and may promote the risk to escalate drug abuse and to relapse (Bruchas 
et al, 2010; Wee and Koob, 2010; Butelman et al., 2012). For this reason, KOP antagonists have 
been proposed to block the aversive effects of withdrawal reducing anxiety-like behavior and to 
counteract stress-induced reinstatement of drug seeking (Wee and Koob, 2010; Schlosburg et al., 
2013). It is worth noting that the increase of dynorphinergic tone in addiction-relevant brain areas 
such as the NAc, amygdala and bed nucleus of the stria terminalis has been postulated as a counter-
regulatory mechanism toward drug-induced dopamine increase (Koob, 2008). In other words, the 
dynorphinergic activation in the NAc works to decrease dopaminergic function (Werling et al, 
1998; Margolis et al., 2003; Koob, 2008) and, indeed, different patterns of cocaine administration 
promote the rapid increase of dynorphin in this brain area (Turchan et al., 1998; Wee and Koob, 
2010; Caputi et al., 2014). In this frame, our data show that repeated developmental exposure to 
cocaine causes a significant pDYN gene expression increase in cocaine-withdrawn rats, thus 
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indicating that the high dynorphinergic tone persists in the absence of cocaine in the NAc. With 
respect to the functional relevance, such increase of pDYN may favour relapse since the 
KOP/dynorphinergic tone inhibition may oppose to the dysphoric state occurring during abstinence 
(Butelman et al., 2012). 
In addition, the increase in pDYN gene expression may also contribute to the depressive-like state 
experienced during short abstinence (Barr et al., 2002; Shirayama and Chaki, 2006). This 
observation is relevant in the light of our previous data revealing that cocaine-withdrawn rats at 
PND45 exhibited a depressive-like behavior in a swim stress paradigm (Caffino et al., 2015b). 
Therefore, the here reported up-regulation of pDYN mRNA levels in the NAc might also participate 
to the pro-depressive state caused by early withdrawal from cocaine. 
According with the hypothesis of a linkage between pDYN and BDNF (Croll et al., 1994; Kim et 
al., 2000; Logrip et al., 2008; Palmisano et al., 2018) and since an increase of BDNF expression in 
the NAc has been shown to mediate pro-depressive behavior (Eisch et al., 2003), we decided to 
investigate BDNF expression and its signaling pathway only after short-term withdrawal, at the 
time point that cocaine abstinence altered pDYN gene expression. We indeed found increased 
expression of both BDNF precursor (proBDNF) and mature BDNF (mBDNF), coupled with the up-
regulation of its high affinity receptor trkB and of Akt, with no effect on ERK2 activation. These 
results suggest that the pro-depressive phenotype we have previously observed in rats exposed to 
cocaine during adolescence (Caffino et al., 2015b) may be, at least in part, due to the up-regulation 
of the BDNF-trkB-Akt pathway in the NAc. 
A different picture can be drawn for the Hip. In this brain region, we observed a significant 
decrease of pDYN gene expression after short abstinence without changes in late withdrawal. We 
previously observed that, after seven days of cocaine infusion, pDYN mRNA levels were unaltered 
in rat Hip (D’Addario et al., 2007b). These data suggest that the herein shown changes in pDYN 
mRNA levels may be due to the withdrawal condition and/or to the period of life of exposure 
(adolescence vs. adulthood). 
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The reduction of pDYN gene expression here reported, after a short abstinence from developmental 
chronic cocaine exposure, might facilitate the increase of glutamate release since, at hippocampal 
level, the dynorphinergic system modulates transmission at all excitatory synapses (Wagner et al., 
1993; Jeub et al., 1999; Terman et al., 2000; Drake et al., 2007). Actually, a recent report analyzed 
the consequences of chronic cocaine intoxication identifying seizures as one of major negative 
effects (Rolland et al., 2011). Therefore, since different studies associate seizures and cocaine 
(Choy-Kwong and Lipton, 1989; Pascual-Leone et al., 1990), it is tempting to speculate that the 
prolonged cocaine exposure during adolescence might induce neurological disorders including 
seizures manifestation likely related to the decrease of the dynorphinergic tone (Simonato and 
Romualdi, 1996). 
Differently from what observed in the NAc, no significant changes of proBDNF, mBDNF and trkB 
protein levels were observed in the Hip of cocaine-withdrawn rats at PND45, indicating that, in this 
brain region, changes in pDYN mRNA levels are not paralleled by changes in BDNF expression. 
Such discrepancy is not surprising since previous studies have shown that the BDNF infusion into 
the Hip of rats decreased dynorphin peptide and mRNA levels (Croll et al., 1994), suggesting that 
BDNF may play a regionally specific role in modulating neuropeptide expression. 
Interestingly, the changes of pDYN expression observed at PND45 vanished when the neuropeptide 
expression was measured at PND90 suggesting that this system is mainly modified during the early 
withdrawal, which is characterized by the occurrence of severe negative emotional states. In 
addition, it is also likely that the lack of pDYN mRNA alterations at PND90 after adolescence 
cocaine exposure could be related to a low sensitivity to cue-induced reinstatement of cocaine 
seeking behavior (Li and Frantz, 2009). 
The N/OFQ system, being widely distributed in brain areas involved in the motivational 
effects of addictive drugs (Neal et al., 1999; Mollereau and Mouledous, 2000), plays a relevant role 
in drug addiction (Witkin et al., 2014) working as a powerful anti-stress system to buffer the 
activation of brain stress systems (Koob, 2015). 
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As mentioned above, the nociceptin system did not show any significant gene expression alteration 
either after short- or long-term withdrawal, in both investigated regions. We previously reported 
that chronic cocaine infusion using osmotic mini-pumps induces significant pN/OFQ-NOP down-
regulation in the NAc (Caputi et al., 2014). However, in that study, gene expression was measured 
immediately after the end of treatment, whereas in the present manuscript analyses have been 
undertaken 3 and 48 days after the last cocaine injection. Hence, the different result here observed 
highlights for the first time that the nociceptinergic response is no longer present in the absence of 
cocaine, i.e. following short- or long-term drug withdrawal, according with the anti-reward activity 
of the N/OFQ-NOP system that is not required during the abstinence phases. 
 
5. Conclusions 
In conclusion, our data show that repeated cocaine exposure during adolescence interferes with the 
dynorphinergic system likely leading to the development of depressive-like phenotype observed 
during early abstinence (Caffino et al., 2015b), through a mechanism that appears to involve up-
regulation of the neurotrophin BDNF and its intracellular signaling. Notwithstanding these results, 
additional research will be necessary to fully elucidate our hypothesis also taking into account that 
the alterations here reported are peculiar of early withdrawal phase, which therefore confirms to be 
a feasible therapeutic window (Butelman et al., 2012). Hence, these results provide further support 
to the notion that the modulation of the dynorphinergic system can be used as therapeutic strategy in 
cocaine addiction (Helal et al., 2017; Valenza et al., 2017). 
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Figure Legends 
Figure 1. Effects of short- (PND45) and long-term (PND90) abstinence from chronic cocaine (20 
mg/kg) or saline exposure during adolescence on a) pDYN, b) KOP, c) pN/OFQ and d) NOP 
mRNA levels in the rat nucleus accumbens (NAc). Data represent 2−DDCt values calculated by DDCt 
method and are expressed as mean ± standard error of the mean (SEM) of six rats per group (* p < 
0.05 vs. PND45 saline; # p < 0.05 vs. PND45 cocaine; data were analyzed by two-way ANOVA 
followed by Bonferroni post hoc test). 
 
Figure 2. Effects of short- (PND45) and long-term (PND90) abstinence from chronic cocaine (20 
mg/kg) or saline exposure during adolescence on a) pDYN, b) KOP, c) pN/OFQ and d) NOP 
mRNA levels in the rat hippocampus (Hip). Data represent 2−DDCt values calculated by DDCt 
20 
 
method and are expressed as mean ± standard error of the mean (SEM) of six rats per group (** p < 
0.01 vs. PND45 saline; # p < 0.05 vs. PND45 cocaine; data were analyzed by two-way ANOVA 
followed by Bonferroni post hoc test). 
 
Figure 3. Effects of short- term (PND45) abstinence from chronic cocaine (20 mg/kg) or saline 
exposure during adolescence on a) proBDNF and mBDNF, b) trkB, c) pAkt S473 and Akt and d) 
pERK2 T202/204 and ERK2 protein levels in the rat nucleus accumbens (NAc). Below each graph, 
representative immunoblots are shown for proBDNF, mBDNF, trkB, pAkt S473, Akt, pERK2 
T202/204 and ERK2 proteins in the homogenate of NAc. Data, expressed as % of saline-treated 
rats, represent the mean ± standard error of the mean (SEM) of five-six rats per group (* p < 0.05 
vs. saline; data were analyzed by unpaired two-tailed Student’s t test). 
 
Figure 4. Effects of short- term (PND45) abstinence from chronic cocaine (20 mg/kg) or saline 
exposure during adolescence on a) proBDNF and mBDNF, b) trkB, c) pAkt S473 and Akt and d) 
pERK2 T202/204 and ERK2 protein levels in the rat hippocampus (Hip). Below each graph, 
representative immunoblots are shown for proBDNF, mBDNF, trkB, pAkt S473, Akt, pERK2 
T202/204 and ERK2 proteins in the homogenate of Hip. Data, expressed as % of saline-treated rats, 
represent the mean ± standard error of the mean (SEM) of six rats per group. 
